Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Celgene spends $100M for option to buy myeloma drug developer Acetylon
Celgene spends $100M for option to buy myeloma drug developer Acetylon
Celgene spends $100M for option to buy myeloma drug developer Acetylon
Submitted by
admin
on July 29, 2013 - 1:36pm
Source:
Fierce Biotech
News Tags:
Celgene
Multiple Myeloma
M&A
Acetylon
Headline:
Celgene spends $100M for option to buy myeloma drug developer Acetylon
Do Not Allow Advertisers to Use My Personal information
